| Date | Title | Description |
| 18.04.2025 | Assort Health: $26 Million Secured For Specialty-Specific GenAI Platform For Managing Patient Phone Calls | Assort Health, which is a specialty-specific AI platform for managing patient phone calls, announced a new round of institutional financing co-led by First Round Capital and Chemistry, with participation from existing investor Quiet Capital... |
| 01.04.2024 | Впервые в мире почку свиньи изменили генетически и пересадили человеку. Теперь их можно массово пересаживать... | Хирурги из США провели человеку трансплантацию почки, полученной из генетически модифицированной свиньи. СМИ сообщают, что данная операция является прорывом в области ксенотрансплантации, когда органы, клетки или ткани пересаживаются из одн... |
| 14.06.2022 | От BioTech к TechBio: как меняется сфера биотехнологий | Биология — одна из самых развитых технологий на Земле. Представьте сотовый телефон, который может расти, воспроизводиться и чинить себя. Именно это умеют делать клетки каждого организма — от бактерии до гигантской секвойи.
Современные проры... |
| 16.05.2022 | Meet Richard Chan, Managing Partner at Berkeley Frontier Fund | Richard Chan, Managing Partner at Berkeley Frontier Fund Richard Chan is a serial entrepreneur and
Venture capital used to be a cottage industry, with very few investing in tomorrow's products and services. Oh, how times have changed! While... |
| 10.01.2022 | Bayer to pay CRISPR-focused Mammoth Biosciences $40 million for gene editing research | Bayer, the German pharmaceutical and agriculture firm, will pay California-based Mammoth Biosciences, a CRISPR-focused startup cofounded by Nobel laureate Jennifer Doudna, $40 million to work on gene-editing technologies in four different d... |
| 27.09.2021 | What Drives Newly Minted Crispr Unicorn Mammoth Biosciences | Mammoth co-founders (from left) Trevor Martin, Janice Chen, and Lucas Harrington Mammoth Biosciences |
| 13.09.2021 | Digital health news, funding roundup in the prior week; September 13 | Beauty Pie raised $100 million; Homage landed $30M; DotCom Therapy picked up $13M
Cleveland Clinic: Cleveland Clinic is an Ohio-based medical center that combines clinical and hospital care with research and education. Anthem is teaming up ... |
| 07.05.2021 | Draper to Develop Biosurveillance Technology for DARPA to Counter the Rapid Spread of Pathogens | Scientists are developing a portable device for screening thousands of pathogens in minutes under DARPA’s Detect It with Gene Editing Technologies (DIGET) program. Credit: Shutterstock "The development of a rapid, low-cost diagnostic d... |
| 03.03.2021 | CRISPR rivals put patents aside to help in fight against Covid-19 | In early January 2020, Feng Zhang, a gene-editing researcher at the Broad Institute of MIT and Harvard, started getting emails written in Chinese about a newly identified coronavirus that was spreading in China. Some were from academics he ... |
| 14.01.2021 | IDbyDNA Announces Engagement in United States Defense Advanced Research Projects Agency (DARPA) Program to Detect Threats using Gene Editing Technologies | "Now more than ever, the world — and particularly, the Department of Defense (DoD) — is in need of innovative solutions that can better identify pathogens and mitigate the spread of disease and other health threats."
SAN FRANCISCO... |
| 30.10.2020 | Mammoth Lands 2 Major Partnerships to Use CRISPR to Solve COVID19 Testing Shortage, At Scale | What You Should Know:
– Mammoth Biosciences signs agreements with MilliporeSigma and Hamilton company targeting commercialization of high-throughput CRISPR-based SARS CoV-2 Test.
– These partnerships will help Mammoth bring a turnkey CRISPR... |
| 12.10.2020 | Meet the 30 young leaders who are forging a new future for the $3.6 trillion healthcare industry | Courtesy of Lori Kearns; Courtesy of Sabah Oney; Incredible Health; Buoy Health; Courtesy of Taison Bell; Samantha Lee/Business Insider This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
Bus... |
| 10.06.2020 | How CRISPR research in Delaware can fight both COVID-19 and inequity in health outcomes | In March, Dr. Eric Kmiec, director of ChristianaCare’s Gene Editing Institute (GEI), and Dr. Jonathan Marron, oncologist at Boston Children’s Hospital and instructor at Harvard Medical School, published the op-ed “Potential Inequities in Ne... |
| 20.05.2020 | Mammoth Biosciences, GSK partner on CRISPR-based Covid-19 diagnostic | On May 7, the FDA granted an emergency use authorization for Cambridge, Massachusetts-based Sherlock Biosciences’ CRISPR diagnostic test for Covid-19, marking the first time the agency had given any kind of authorization to a CRISPR-based p... |
| 20.05.2020 | Mammoth Biosciences partners with GSK to develop handheld CRISPR-based COVID-19 test | California-based Mammoth Biosciences has signed a powerful partner for its development of a CRISPR-based test for COVID-19, which would aim to deliver accurate, fast results using a handheld, disposable testing platform. Mammoth Biosciences... |
| 01.04.2020 | Coronavirus Business Tracker: How The Private Sector Is Fighting The Covid-19 Pandemic | Alain Mérieux, founder of BioMérieux.AFP via Getty Images |
| 26.03.2020 | What it’s like to go into the lab at a biopharma company during the coronavirus pandemic | Like grocery store clerks and Amazon delivery drivers, they’re among the essential workers of the coronavirus pandemic: the biopharma employees who must still go in to the lab or the manufacturing plant. But for these employees, going to wo... |
| 01.02.2020 | Mammoth Biosciences Raises $45 Million For Crispr Diagnostics | - |
| 31.01.2020 | StartUPDATES: New developments with healthcare startups | California based Cardinal Analytx Solutions has rebranded as Prealize. The name change reflects the transformation into a company that can support the delivery of proactive healthcare by connecting predictions of potential risk across entir... |
| 30.01.2020 | Mammoth Biosciences raises $45M Series B round for CRISPR diagnostics, therapeutics development | “As a team on the front lines of discovery in CRISPR, we’ve seen firsthand the need for new tools to deliver on the therapeutic and diagnostic promise that this technology has to offer,” Mammoth CEO Trevor Martin said in a statement. “In po... |
| 30.01.2020 | Daily funding roundup - January 30th, 2020 | Maze raised $2M; Vero Leasing closed $3.2M; Coda landed $4M; Haus picks up $4.5M
Maze: Maze is a usability testing startup. Maze has raised $2 million in funding led by Amplify Partners, with participation from previous backers Seedcamp and... |
| 30.01.2020 | Mammoth Biosciences raises $45M to expand into therapeutics | The company, which uses CRISPR technology to diagnose diseases, will being treating disease as well
By now most of us have at least heard of CRISPR, but maybe we don't know what exactly it is. CRISPR, essentially, is a tool that make it eas... |
| 30.01.2020 | Mammoth Biosciences aims to be Illumina for the gene editing generation | In 1998, the startup company Illumina launched a revolution in the life sciences industry by developing technology to slash the costs of identifying and mapping genetic material.
Now, a little over 20 years later, Mammoth Biosciences is hop... |
| 14.03.2019 | Mammoth Biosciences adds the final piece of the CRISPR diagnostics puzzle to its toolkit | With the announcement today that Mammoth Biosciences has received the exclusive license from the University of California, Berkeley to the new CRISPR protein Cas14, the company now has the last piece of its diagnostics toolkit in place.
Cas... |
| 07.08.2018 | Mammoth Biosciences raises $23M for its CRISPR-based disease detection engine | - |
| 01.08.2018 | Term Sheet — Wednesday, August 1 | TRASH TALK
Good morning, Term Sheet readers.
Paid Content What you need to know about growing cyberattacks From ExtraHop
This is a rather surprising move as Rubicon has long marketed itself as the “Uber for trash,” and being a waste brokera... |
| 01.08.2018 | A medical diagnostics startup that wants to use CRISPR technology to detect diseases just raised $23 million in venture funding | Mammoth Biosciences
The science team behind Mammoth Biosciences
Advertisement
Mammoth Biosciences announced a $23 million funding round on Tuesday, setting the company up to try and make a dent in the $45 billion global disease detection ma... |
| 31.07.2018 | Mammoth Biosciences raises $23M to democratize diagnostics | The company is a CRISPR-based disease detection platform for at-home use
Of all of the ways medicine and healthcare have changed in recent years, one of the most profound has been the increase of at-home testing. So many things that patient... |
| 27.04.2018 | Top tech startup news stories you need to know this Friday, April 27 | Good morning! Here are some of the top tech startup news stories today Friday, April 27.
Mammoth Biosciences is a new startup that wants to use CRISPR to diagnose disease. Mammoth Biosciences, the CRISPR-based platform for disease detectio... |
| 26.04.2018 | Doudna’s latest CRISPR company debuts, joining the crowds in diagnostics and genome-editing | And then there were … oh, forget it: We’ve given up trying to count the number of CRISPR companies, but we can tell you that one more came out of stealth mode on Thursday. After a year spent wooing investors, hiring, and refining its plans,... |
| - | Mammoth Biosciences raises $45M Series B round for CRISPR diagnostics, therapeutics development | A company developing a means of using gene-editing technology to detect disease has raised its latest funding round to continue its diagnostics work.
South San Francisco, California-based Mammoth Biosciences said Thursday that it had raised... |
| - | Mammoth Biosciences, GSK partner on CRISPR-based Covid-19 diagnostic | Two weeks after the Food and Drug Administration granted its first-ever authorization to a product based on CRISPR, in the form of a diagnostic test for SARS-CoV-2, another firm is partnering with a large drugmaker to develop a rapid test f... |
| - | StartUPDATES: New developments with healthcare startups | In response to the CDC’s release of clinical criteria to guide the evaluation of patients under investigation (PUI) for Wuhan coronavirus (2019-nCoV), Bright.md updated its Upper Respiratory Infection (URI) SmartExamTM modules to include co... |
